Will Bactrim (trimethoprim‑sulfamethoxazole) be effective for an uncomplicated urinary tract infection with positive nitrites and leukocyte esterase?

Bactrim for UTI with Positive Nitrites and Leukocytes

Bactrim (trimethoprim-sulfamethoxazole) can effectively treat an uncomplicated urinary tract infection with positive nitrites and leukocyte esterase, but only if local resistance rates to this antibiotic are known to be below 20% or if you can reasonably assume low resistance in your patient population. 1

Key Decision Point: Local Resistance Rates

The critical factor determining whether to use Bactrim is your local E. coli resistance pattern:

• If local TMP-SMX resistance is <20%: Bactrim is appropriate as empiric therapy (160/800 mg twice daily for 3 days) 1
• If local resistance is ≥20% or unknown: Choose nitrofurantoin instead (100 mg twice daily for 5 days) 1

The 20% threshold exists because clinical cure rates drop dramatically with resistant organisms—from 84% with susceptible strains to only 41% with resistant strains 1. This represents a clinically unacceptable failure rate that directly impacts patient morbidity.

Why Nitrites and Leukocytes Don't Change the Recommendation

The presence of positive nitrites and leukocyte esterase confirms you're dealing with a bacterial UTI (most likely E. coli), but these findings do not predict antibiotic susceptibility 2, 3. Research shows that nitrite-positive urine actually correlates with higher resistance rates to TMP-SMX 2, making the resistance threshold even more important to consider.

Preferred First-Line Approach

Nitrofurantoin monohydrate/macrocrystals is now the preferred first-line agent for uncomplicated cystitis due to minimal resistance (<5% in most regions) and comparable efficacy to Bactrim 1. Clinical cure rates are 90% at 5-9 days and 84% at 30 days 1.

When Bactrim Remains Appropriate

Bactrim is FDA-approved for UTI treatment 4 and achieves excellent outcomes when organisms are susceptible:

• Early clinical cure: 86-100% 1
• Early bacterial cure: 85-100% 1
• Late clinical cure: 79-90% 1

Use Bactrim when:

• Local resistance data confirms <20% resistance
• Patient has contraindications to nitrofurantoin (renal impairment with CrCl <30 mL/min)
• Nitrofurantoin is unavailable or not tolerated
• Culture results confirm susceptibility

Critical Caveats

Do not use Bactrim if:

• The patient used TMP-SMX in the preceding 3-6 months (independent risk factor for resistance) 1
• Local resistance rates are unknown and you practice in an area with high antibiotic resistance
• The patient has risk factors for resistant organisms (recent healthcare exposure, recurrent UTIs)

Hospital antibiograms overestimate community UTI resistance 5, so don't rely solely on these for empiric decisions—they reflect complicated infections, not uncomplicated cystitis.

Practical Algorithm

1. Check local resistance data for community E. coli causing uncomplicated UTI
2. If resistance <20%: Bactrim 160/800 mg (1 DS tablet) twice daily × 3 days 1
3. If resistance ≥20% or unknown: Nitrofurantoin 100 mg twice daily × 5 days 1
4. If treatment fails: Obtain urine culture and switch based on susceptibilities

The positive urinalysis confirms bacterial infection requiring treatment, but the choice between Bactrim and nitrofurantoin hinges entirely on local resistance patterns, not the urinalysis findings themselves.